Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Endocrine 1

Conditions

Postoperative Complications 1Polycystic Ovary Syndrome 1Multiple Endocrine Neoplasia Type 1 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulin Resistance 1Dwarfism 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Growth Hormone × Clear all
NCT03717168 2019-08-21

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Postoperative Complications

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Universidade Federal do Rio de Janeiro

Phase 4 Completed
13 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT01901666 2013-07-17

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

PIMERIndia

Phase 4 Unknown
20 enrolled
MyeloidOther hematologic neoplasm

Dwarfism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡